Cost of revenue increased 37.6%
Cost of revenue changed +37.6% from the comparable as-filed period.
$5.2M→$7.1M3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →TZOO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed across a sign change
Operating income changed -234.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$2.1M→-$2.8M3 prior comparisons
Capital expenditure decreased 53.8%
Capital expenditure changed -53.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$13,000→$6,0004 prior comparisons
Net income changed across a sign change
Net income changed -252.4% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$1.4M→-$2.1M3 prior comparisons
Free-cash-flow margin moved 1258 bp lower
Free-cash-flow margin changed -1258 basis points from the comparable as-filed period.
5.38%→-7.20%3 prior comparisons
Operating cash-flow margin moved 1260 bp lower
Operating cash-flow margin changed -1260 basis points from the comparable as-filed period.
5.43%→-7.17%3 prior comparisons
Research & development decreased 13.8%
Research & development changed -13.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$698,000→$602,0003 prior comparisons
Gross profit decreased 14.1%
Gross profit changed -14.1% from the comparable as-filed period.
$18.7M→$16.1M3 prior comparisons
Shares outstanding decreased 7.1%
Shares outstanding changed -7.1% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes.
10,980,939→10,202,3377 prior comparisons
Revenue decreased 2.9%
Revenue changed -2.9% from the comparable as-filed period.
$23.9M→$23.2M3 prior comparisons
SBC / revenue moved 153 bp higher
SBC / revenue changed +153 basis points from the comparable as-filed period.
1.42%→2.95%3 prior comparisons
Current ratio decreased 7.0%
Current ratio changed -7.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
0.69→0.644 prior comparisons
Capex / revenue moved 3 bp lower
Capex / revenue changed -3 basis points from the comparable as-filed period.
0.05%→0.03%3 prior comparisons
Current assets increased 4.6%
Current assets changed +4.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$24.2M→$25.3M4 prior comparisons
Total assets increased 2.3%
Total assets changed +2.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$46.7M→$47.8M4 prior comparisons
R&D / revenue moved 33 bp lower
R&D / revenue changed -33 basis points from the comparable as-filed period.
2.92%→2.59%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.